Meribank Biotech Co (ROCO:4724) Ending Cash Position : NT$399.5 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Ending Cash Position?

Meribank Biotech Co's Ending Cash Position for the quarter that ended in Dec. 2023 was NT$399.5 Mil.

Meribank Biotech Co's quarterly Ending Cash Position declined from Dec. 2022 (NT$85.2 Mil) to Jun. 2023 (NT$61.6 Mil) but then increased from Jun. 2023 (NT$61.6 Mil) to Dec. 2023 (NT$399.5 Mil).

Meribank Biotech Co's annual Ending Cash Position declined from Dec. 2021 (NT$192.2 Mil) to Dec. 2022 (NT$85.2 Mil) but then increased from Dec. 2022 (NT$85.2 Mil) to Dec. 2023 (NT$399.5 Mil).

Meribank Biotech Co Ending Cash Position Historical Data

The historical data trend for Meribank Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Ending Cash Position Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

55.17

51.40

192.15

85.16

399.46

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial							192.15	128.32	85.16	61.56	399.46

Meribank Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Meribank Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	85.159	+	314.299
	=	399.5

Meribank Biotech Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	61.562	+	337.896
	=	399.5

Meribank Biotech Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines